Product information

Current status:

Dormant

Current status date:

2018-07-24

Original market date: ^{See footnote 1}

1991-01-30

Product name:

BALMINIL NASAL DECONGESTANT

DIN:

00791172 Electronic product monograph is not available

Company:

TEVA CANADA LIMITED
30 Novopharm Court
Toronto
Ontario
Canada M1B 2K9

Class:

Human

Dosage form(s):

Spray

Route(s) of administration:

Nasal

Number of active ingredient(s):

1

Schedule(s):

OTC

American Hospital Formulary Service (AHFS): ^{See footnote 3}

52:32.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

R01AA07 XYLOMETAZOLINE

Active ingredient group (AIG) number:^{See footnote5}

0107655001